Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01407263 · ClinicalTrials.gov registry record · Phase 3

Trial of Modifications to Radical Prostatectomy

A Phase 3 study of Prostate Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
Phase 3
Development phase
3,204
Enrollment target
5
Study locations

NCT01407263: Active Phase 3 study of Prostate Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT01407263 is a Phase 3 study of Prostate Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3,204 participants, above the 604-participant average among 735 other Prostate Cancer trials with a reported enrollment target (430% higher). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01407263, a Phase 3 study of Prostate Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
3,204 participants
Enrollment target
5
Study locations

Study Summary

This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph node has cancer. Surgeons make sure to remove those affect lymph nodes and all other lymph nodes in the area. However, it is not known whether removing lymph nodes helps prostate cancer patients whose scans do not show positive nodes. In this study, patients with clear scans will either receive a lymph node dissection or not."

Conditions Studied

Prostate Cancer

Interventions

  • PROCEDURE Lymph node template
  • PROCEDURE Transverse versus vertical closure
  • DRUG antibiotic prophylaxis
  • DRUG Hemostatic Agent

Study Locations (5)

New York

  • Memorial Sloan Kettering Westchester - Harrison
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering Cancer Center @ Nassau (Consent only) - Uniondale

New Jersey

  • Memorial Sloan Kettering Cancer Center at Basking Ridge - Basking Ridge
  • Memorial Sloan Kettering Bergen (Consent Only) - Montvale

Trial Details

FieldValue
Enrollment Target 3,204 participants
Start Date 2011-07
Est. Completion 2026-07
Phase Phase 3

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01407263

The ClinicalTrials.gov registry entry for NCT01407263 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 3,204 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 604-participant average among 735 other Prostate Cancer trials with a reported enrollment target (430% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which Lymph node template is the first listed.

NCT01407263 reports 5 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT01407263 about?

NCT01407263 is a clinical study titled "Trial of Modifications to Radical Prostatectomy". This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph node has cancer. Surgeons make sure to remove those affect lymph nodes and all other lymph nodes in the area. However, ...

What is the current status of trial NCT01407263?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 3,204 participants. The study started on 2011-07. Estimated completion is 2026-07.

What conditions does trial NCT01407263 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT01407263?

The interventions under investigation include: Lymph node template (PROCEDURE), Transverse versus vertical closure (PROCEDURE), antibiotic prophylaxis (DRUG), Hemostatic Agent (DRUG).

Who is sponsoring clinical trial NCT01407263?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01407263 being conducted?

This trial has 5 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.